Thinking Out Loud (Blog)
IAVI Report Revisited: Lessons from HIV research for SARS-COV-2 vaccine design
When EpiVax CEO/CSO Annie De Groot began her decades-long focus on HIV vaccine research in the early 90’s, she couldn’t have predicted the implications for the COVID-19 pandemic…. Or perhaps she did! Interviewed by Michael Dumiak for August 2020 issue of IAVI, Annie...
read more
ConvergenceRI: Truly a Beautiful Day in the Neighborhood
Annie De Groot, CEO/CSO for EpiVax Inc, had a chance to sit down(virtually!) with Richard Asinof of CovergenceRI and Frank Casale, regional VP of TD Bank to discuss some big developments over at Clínica Esperanza. Clínica Esperanza, “Hope Clinic,” is located in the...
read more
February Newsletter: Jack as Co-pilot and Zoom buddy
Zoom Fatigue is REAL! Like you, we've been insanely busy with virtual conferences in the last few weeks. We are all REALLY looking forward to meeting in person again. Meanwhile, my Zoom-buddy Jack has become quite the lap(top)-dog! The good news is that we have...
read more
Valerie’s Secret Formula for Predicting Immunogenicity
The in silico tools here at EpiVax have been extensively validated, both internally and externally. That said, we always get a warm fuzzy feeling when we see our tools highlighted in papers and at conferences! Proud parents, we can’t help it😊 Just such a moment...
read more
January Newsletter: Duality Over Division
Fluidity over Division I have a confession to make. I am transfixed by Kpop. Well, actually, just BTS. I hadn't been paying attention, honestly, until Kpop fans upended a Trump campaign event in Tulsa. And one thing led to another and there they were. Who are...
read more
December Newsletter: 2020 Hindsight! and Paying it Forward
2020 Hindsight and Paying it Forward It has been an upside down year during which time we've learned a lot about our ability to work from home and still carry out global collaborations. EpiVax embraces the positive changes that have occurred and celebrates the impact...
read more